Hyperparathyroidism and Asthenia. A New Deal?
Journal: International Journal of Clinical Endocrinology and Metabolism (Vol.3, No. 1)Publication Date: 2017-12-07
Authors : S Li Sun Fui; P Bonnichon;
Page : 046-047
Keywords : ;
Abstract
The profile of primary hyperparathyroidism (PHPT) changed profoundly over the course of the twentieth century. The highly symptomatic forms reported in the 1960s have progressively been replaced by forms with few symptoms and in some cases totally asymptomatic forms. As of 1991, with the increasing frequency of these new forms, several consensus meetings designed to defi ne the criteria for stablishing theoperability of minimally-symptomatic hyperparathyroidism have been organized [1]. However, the criteria chosen are in some cases deemed too restrictive as they do not take into account general and neuro-psychic symptoms which are frequently associated [2].
Other Latest Articles
- Preparation and Application of two Monoclonal Antibodies against Canine Parvovirus Vaccine and Field Strains
- Construction of Indonesian-Strain Avian Flu Virus Seed Vaccine Using Low Pathogenic Hemagglutinin Gene and Neuraminidase Pr8 Gene through Reverse Genetics
- Measuring autophagy level along with vaccine reactive IFN-γ+CD4+ Th1 cells may be a promising approach to understand efficacy of anti TB vaccine(s)
- Human zygote reconstruction by spindle, polar body or pronuclear transfer to treat repeated embryo fragmentation or embryo developmental arrest: The future is now
- Association of genetic polymorphisms in DNA repair genes in polycystic ovary syndrome
Last modified: 2019-01-11 17:58:07